Gram Research analysis of a 2026 Global Burden of Disease study finds that esophageal cancer deaths in China fell sharply, with age-adjusted death rates dropping about 3.6% per year from 1990 to 2023. China still accounted for 59.8% of Asia’s esophageal cancer deaths in 2023, and smoking and heavy drinking remained the leading risk factors.
Esophageal cancer is a serious cancer of the food pipe that connects the throat to the stomach. According to research reviewed by Gram, a large 2026 study using Global Burden of Disease data found that cases and deaths in China have dropped steadily since 1990. Once age is taken into account, China’s death rate fell by about 3.6% per year from 1990 to 2023. Even so, China still carried the largest share of this cancer in Asia, accounting for about 60% of the region’s deaths in 2023. Smoking and heavy drinking remained the two leading risk factors. Men were affected far more often than women. The researchers noted that a growing and aging population is pushing total case numbers up, even as the risk per person goes down. They suggest that cutting tobacco and alcohol use, along with better screening for high-risk people, will be key to lowering the future burden.
Key Statistics
A 2026 analysis of Global Burden of Disease 2023 data found that China accounted for about 59.8% of Asia’s esophageal cancer deaths in 2023, with 254,462 deaths out of 425,429 across the region.
The same 2026 Global Burden of Disease analysis found that China’s age-adjusted esophageal cancer death rate fell by about 3.6% per year between 1990 and 2023.
A 2026 study covering 33 Asian countries and territories found that South Asia was the only region where esophageal cancer death rates rose, increasing by about 1.8% per year.
The Quick Take
- What they studied: How common esophageal cancer is across Asia, how many people die from it, and how these numbers have changed since 1990, with a closer look at China.
- Who participated: The study did not enroll patients. It used national health estimates for 33 Asian countries and territories, grouped into five regions, covering men and women of all ages from 1990 to 2023.
- Key finding: In 2023, East Asia had the heaviest burden, with about 261,000 deaths. China accounted for about 59.8% of Asia’s esophageal cancer deaths, and its age-adjusted death rate fell by about 3.6% per year between 1990 and 2023.
- What it means for you: Quitting smoking and cutting back on heavy drinking are among the most effective ways to lower your personal risk of esophageal cancer. Regular medical checkups and screening may also help if you belong to a high-risk group. This research describes population trends and cannot tell you your individual risk.
The Research Details
The researchers used the Global Burden of Disease 2023 project, a large effort that collects and combines health data from around the world. They pulled together estimates of how many people developed esophageal cancer, how many died from it, and how many healthy years of life were lost to it. They looked at each sex and age group across five Asian regions and 33 countries and territories.
To make fair comparisons across time and places, the team used age-standardized rates. These rates adjust for the fact that some populations have more older people, who are naturally more likely to get cancer. They also calculated an average yearly percentage change to show whether the burden was going up or down over time.
The team also estimated how much of the disease could be linked to specific risk factors, such as smoking, heavy drinking, diet, and tobacco chewing. They then broke down the total change into parts caused by population growth, population aging, and changes in disease rates.
Looking at the whole region, rather than one country at a time, shows where the disease is concentrated and how it is shifting. Because the method adjusts for age and population size, it is possible to see whether a country is truly improving or just has more older residents. Identifying risk factors also helps public health leaders decide where prevention efforts will have the biggest effect.
Global Burden of Disease estimates are built from many data sources and are widely used by health agencies worldwide. The results include uncertainty ranges, which show how precise each estimate is. However, this is a modeling study rather than a clinical trial, so it can show patterns and links but cannot prove that a specific factor caused a specific outcome. The reliability of the numbers also depends on the quality of the data available in each country.
What the Results Show
East Asia remained the region with the heaviest burden in 2023, with about 261,000 deaths from esophageal cancer. Its age-standardized death rate was about 10.9 per 100,000 people. These figures show that the disease is still a major health problem in this part of the world.
The trends differed by region. Central Asia showed the largest decline, with its death rate falling by about 3.7% per year. South Asia was the only region where the death rate rose, increasing by about 1.8% per year. The researchers linked this rise mainly to chewing tobacco and diets low in vegetables.
China stood out as the largest contributor. In 2023, it accounted for about 59.1% of Asia’s new cases, about 59.8% of deaths, and about 55.7% of the healthy years of life lost. Even so, China’s age-adjusted rates dropped sharply, with the death rate falling by about 3.6% per year and the rate of new cases falling by about 3.4% per year.
Smoking and heavy alcohol use were the two leading risk factors in China and across East Asia and the high-income Asia-Pacific region. The disease hit men much harder than women. The researchers found that population growth and aging were the main reasons total deaths kept rising, even though the risk for each person was going down. This means that more people are living long enough to reach the age when this cancer is most common.
These findings build on earlier global estimates showing that esophageal cancer is especially common in Asia, which accounts for roughly 80% of cases worldwide. The strong link between smoking, heavy drinking, and this cancer has been well documented in earlier studies. The main new contribution is a detailed regional breakdown, including the finding that South Asia is moving in the opposite direction from the rest of the continent.
This study relies on estimates rather than direct counts of every case, so the numbers include a margin of uncertainty. Data quality varies between countries, and some regions may have less reliable records. The study looks at patterns across populations and cannot show how any one person’s habits affect their own risk. It also cannot prove cause and effect. Finally, the researchers did not report the sample size as a single number because the analysis uses modeled estimates for each country.
The Bottom Line
Research shows that smoking and heavy drinking are the two biggest controllable risk factors for esophageal cancer in Asia, so reducing or quitting both is strongly supported by the evidence. Health experts also suggest that screening for people at high risk may help catch the disease earlier. Confidence in the link between smoking, drinking, and this cancer is high. Confidence in the specific benefits of any single screening program is more moderate and varies by population.
Adults who smoke, drink heavily, or have a family history of esophageal cancer should pay the most attention. Public health planners, clinicians, and people living in Asia may find the regional patterns especially useful. People who do not smoke or drink heavily can still benefit from general healthy habits, but this study does not provide specific guidance for them.
Quitting smoking and cutting back on alcohol can lower cancer risk over years, not weeks. Some of the risk declines over time after a person stops smoking, and the benefits build gradually. Population-level changes in this study took decades to show up, so individual progress will also be gradual and should be discussed with a doctor.
Frequently Asked Questions
What are the main causes of esophageal cancer in Asia?
Smoking and heavy alcohol use are the two leading risk factors in East Asia and China, according to a 2026 Global Burden of Disease analysis. In South Asia, chewing tobacco and diets low in vegetables were linked to rising rates.
Is esophageal cancer getting better or worse in China?
Age-adjusted rates in China have improved. The death rate fell by about 3.6% per year from 1990 to 2023, though total cases remain high because the population is growing and aging.
How many people die from esophageal cancer in Asia each year?
East Asia recorded about 261,000 esophageal cancer deaths in 2023, the most of any Asian region. China alone accounted for roughly 254,000 deaths across Asia that year, according to the Global Burden of Disease 2023 study.
Why do more men than women get esophageal cancer?
The Global Burden of Disease 2023 study found that men carry a considerably higher burden than women. The gap is largely linked to higher rates of smoking and heavy drinking among men in Asia.
Want to Apply This Research?
- Log the number of cigarettes smoked each day and the number of alcoholic drinks consumed each week. Track your progress toward a specific goal, such as zero cigarettes or no more than two drinks per week, and review it weekly.
- Set a small, specific goal, such as skipping alcohol on weeknights or replacing one daily cigarette with a nicotine replacement or a planned break. Use the app to schedule reminders for these goals and to celebrate each week you meet them.
- Review your smoking and drinking logs every month to spot trends. Schedule regular checkups with a doctor and note when screenings are due. Over time, compare your logs with your health goals and share the summary with your healthcare provider.
This article summarizes a population-level research analysis and is for general information only. It does not describe your personal risk and should not replace advice from a doctor. If you have trouble swallowing, persistent chest or throat pain, unexplained weight loss, or other concerning symptoms, please see a healthcare professional promptly. Anyone thinking about changing their diet, quitting smoking, or starting a screening program should talk with a qualified clinician first.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.